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 BACKGROUND 
 
 Nowadays, the need to formulate medicines specifically designed for children is imperative[1] and solid dosage forms are the first choice for providing the required drug stability and dose accuracy. Milk, as a 
worldwide accepted food, is proposed in this study as a platform to deliver drugs orally in pediatrics.  
 
 The main goals of this work were (a) the assessment of the properties of spray-dried fresh milk powders, (b) the evaluation of drug-milk interactions and (c) to ascertain the stability of the spray-dried milk powders. 
 
 
MATERIALS AND METHODS 
 
 
 
 Quantification of theophylline in the spray-dried milk powders revealed that samples above 0.31 of 
theophylline fraction failed to have all drug present in the initial theophylline : milk solutions. During the 
spray-drying process, considerable losses of theophylline were observed for samples above 0.31 of 
theophylline fraction, which was in line with the results from the assays (HPLC). 
 
3. Drug-milk interaction 
 Data from the calorimetric studies has shown that above 0.62 of theophylline content, regardless the fat 
content, revealed that the drug was not completely solubilized by milk components and, therefore, 
endotherms due to melting of theophylline started to appear in the thermograms. This finding was also 
corroborated by the microscopic analysis where theophylline crystals were predominantly observed in the 
samples mentioned earlier, indicating a limited capacity of milk to incorporate the drug. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: DSC thermogram of MFM powders atomized at 150 C and theophylline crystal observed by polarized light 
a) Spray-dried milk; b)Theophylline-milk 0.08:1; c) Theophylline-milk 0.16:1; d) Theophylline-milk 0.31:1; e) Theophylline-milk 0.62:1;  
f) Theophylline-milk 1:1; g) Theophylline raw material 
 
 Due to an existing peak overlap of theophylline and spray-dried powdered milk components, the FT-IR 
results have shown that, when the milk components were present in higher fractions, the peaks in the amine 
region of the spectra due to theophylline were less intense (e.g. 3125-3120cm-1 region). No peak due to the 
resulting imine group from the Maillard’s reaction (1647-1630cm-1) was observed. Furthermore, no new 
bond formation was observed in any spectra (data not shown). 
 
4. Stability 
 Shelf-life stability testing of powders has proven that the amount of drug in the spray-dried powders 
remained constant for 6 months. Regarding in-use stability of reconstituted powders in water, at room 
temperature, microbial content criteria[4] were met by all samples at 24h, regardless of their fat content. At 4ºC, 
criteria were met by all samples at 48h, but only LFM samples met the criteria, 7 days after reconstitution 
(Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Stability in-use of drug-containing milk powders, after reconstitution in water.  
Arrows indicate the last time point at which the compendial limits were met. 
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CONCLUSIONS 
 
 This study suggests that a spray-dried milk drug loaded powder is a promising platform to deliver drugs orally in pediatrics.  
 The powders obtained were stable after an easy extemporaneous reconstitution. 
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